Board Meeting23 Jun 2026, 05:40 pm
Bacil Pharma Board Meeting on June 26 to Consider Fund Raising
AI Summary
Bacil Pharma Ltd has announced that its Board of Directors will convene on June 26, 2026, to discuss and approve proposals for raising funds. The company is exploring various permissible modes, including Preferential Issue, Rights Issue, or a combination thereof, subject to regulatory approvals. The meeting agenda also includes transacting any other business with the Chairman's permission. Concurrently, the trading window for designated persons and their relatives will be closed from today until 48 hours after the board meeting's outcome is declared, in line with SEBI's insider trading regulations.
Key Highlights
- Board meeting scheduled for June 26, 2026.
- To consider and approve fund-raising proposals.
- Potential modes include Preferential Issue and Rights Issue.
- Trading window closed for designated persons.
- Outcome to be intimated to the stock exchange.
Price Impact
More from BACPHAR